GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skinvisible Inc (OTCPK:SKVI) » Definitions » ROCE %

Skinvisible (Skinvisible) ROCE % : 0.00% (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Skinvisible ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Skinvisible's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.00%.


Skinvisible ROCE % Historical Data

The historical data trend for Skinvisible's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skinvisible ROCE % Chart

Skinvisible Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Skinvisible Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Skinvisible ROCE % Calculation

Skinvisible's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-0.495/( ( (0.247 - 3.645) + (0.163 - 3.512) )/ 2 )
=-0.495/( (-3.398+-3.349)/ 2 )
=-0.495/-3.3735
=14.67 %

Skinvisible's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-0.496/( ( (0.163 - 3.512) + (0.153 - 4.094) )/ 2 )
=-0.496/( ( -3.349 + -3.941 )/ 2 )
=-0.496/-3.645
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Skinvisible  (OTCPK:SKVI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Skinvisible ROCE % Related Terms

Thank you for viewing the detailed overview of Skinvisible's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Skinvisible (Skinvisible) Business Description

Traded in Other Exchanges
N/A
Address
6320 South Sandhill Road, Suite 10, Las Vegas, NV, USA, 89120
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.
Executives
St James David M director 3395 S. JONES BLVD., #169, LAS VEGAS NV 89146
Doreen Mcmorran 10 percent owner 6320 S. SANDHILL RD UNIT 10, LAS VEGAS NV 89120
Brian Piwek director 9014 GLENEAGLE DRIVE, BLAINE WA 98230
E Greg Mccartney director #307-15338 18TH AVENUE, SURREY BC A1 V4A 1W8
Jost Steinbruchel director 7, RUE DES BATTOIRS, POBOX #214, 1211 GENEVA 4 V8 000000
Robert F Lutz director, 10 percent owner
Terry Howlett director, 10 percent owner, officer: President & Chief Exec.Officer 6320 S. SANDHILL ROAD, SUITE #10, LAS VEGAS NV 89120
Skinvisible Inc director, 10 percent owner, officer: President 6320 S SANDHILL ROAD, SUITE 10, LAS VEGAS NV 89120
Lutz Family Trust 10 percent owner 8322 WEST TONTO LANE, PEORIA AZ 85382